Riskpilot← Back to searchSign inGet full accessBIOMEGA GROUP AS
ASActiveOrg 982219787Thormøhlens Gate 53D, 5006 BergenProcessing and preserving of fish, crustaceans and molluscs · NACE 1020Est. 200014 employeeswww.biomegagroup.com
Revenue 2024
NOK 50,1M
+29% vs 2023
EBITDA margin
-9.4%
+14% vs 2023
Equity ratio
80.8%
Financial strength
Net profit 2024
NOK -128,9M
-322% vs 2023
| Revenue | NOK 50,1M | +29% |
| EBITDA | NOK -4,7M | +14% |
| Net profit | NOK -128,9M | -322% |
| Total assets | NOK 565,1M | -19% |
| Equity | NOK 456,4M | -22% |
| Employees | 14 | — |
Legal name
BIOMEGA GROUP AS
Org number
982219787
Legal form
Aksjeselskap
NACE code
1020 · Processing and preserving of fish, crustaceans and molluscs
Founded
8. august 2000
Share capital
NOK 18 357 163
Employees
14 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og to styremedlemmer i fellesskap.
Company purpose
Utvikle, produsere og markedsføre høyverdige produkter basert på ferske marine råstoffer, samt delta i andre selskaper med samme formål.
Address
Thormøhlens Gate 53D, 5006 Bergen
Phone
+4755629450
Email
contact@biomegagroup.com
Website
www.biomegagroup.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 18 386 | 30 953 | 35 378 | 38 884 | 50 072 |
| Staff expenses | −13 718 | −13 928 | −21 406 | −21 014 | −0 |
| EBITDA | −17 031 | 2 682 | −2 347 | −5 460 | −4 717 |
| Depreciation & amort. | −1 783 | −5 411 | −3 652 | −3 011 | −2 035 |
| EBIT | −18 814 | −2 729 | −5 998 | −8 471 | −6 752 |
| Net financials | 3 660 | −1 195 | 9 651 | 67 152 | −119 544 |
| Profit before tax | −15 154 | −3 924 | 3 653 | 58 681 | −126 296 |
| Tax | −0 | −0 | −0 | 524 | 2 585 |
| Net profit | −15 154 | −3 924 | 3 653 | 58 157 | −128 881 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 416 986 | 510 789 | 650 249 | 696 160 | 565 100 |
| Equity | 314 654 | 487 748 | 527 141 | 585 298 | 456 417 |
| Long-term debt | 80 291 | 1 400 | 98 650 | 92 696 | 80 756 |
| Short-term debt | 22 041 | 21 640 | 24 458 | 18 166 | 27 927 |
| Total debt | 102 332 | 23 040 | 123 108 | 110 862 | 108 683 |
EBITDA margin
-9.4%
This company
15.8%
Market median
-159% vs market
20202024
Equity ratio
80.8%
This company
38.2%
Market median
+112% vs market
20202024
Return on equity
-28.2%
This company
18.4%
Market median
-253% vs market
20202024
Net profit margin
-257.4%
This company
8.1%
Market median
-3278% vs market
20202024
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20202024
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
AQ Chief Executive Officer | Chief Executive Officer | 2026 |
OP Chief Executive Officer | Chief Executive Officer | 2025 |
GO Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
SV Chief Executive Officer | Chief Executive Officer | 2021 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (10) | ||
| Chairman | 2021 | |
| Board of Directors | 2026 | |
| Board of Directors | 2021 | |
| Board of Directors | 2026 | |
| Board of Directors | 2023 | |
| Chairman | 2026 | |
| Board of Directors | 2021 | |
| Chairman | 2026 | |
| Board of Directors | 2026 | |
| Board of Directors | 2024 | |
| Former (3) | ||
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2021 – 2023 | |
| Board of Directors | 2023 – 2024 | |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BIOMEGA GROUP AS 
RAGN-SELLS HAVBRUK ASBoard members of BIOMEGA GROUP AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Quamme Fosse | Chief Executive Officer | 0 companies |
| Stig Victor Petersen | Chief Executive Officer | 0 companies |
| Ole Petter Wie | Chief Executive Officer | 0 companies |
| Geir Olav Melingen | Chief Executive Officer | 0 companies |
| Sten Estrup Nielsen | Chairman | 0 companies |
| Harald Idar Hagen | Board of Directors | 0 companies |
| Kjartan Erik Sandnes | Board of Directors | 0 companies |
| Liv Monica Bargem Stubholt | Board of Directors | 0 companies |
| Bente Jeanette Foss | Board of Directors | 0 companies |
| Hege Charlotte Bakken | Board of Directors | 0 companies |
| Espen Aanderud | Chairman | 0 companies |
| Craig Armen Tashjian | Board of Directors | 0 companies |
| Tanja Elisabeth Knabenschuh Hoel | Chairman | 0 companies |
| David Andrew Barley | Board of Directors | 0 companies |
| Ann Kristin Feidje | Board of Directors | 0 companies |
| Simon John Dent | Board of Directors | 0 companies |
| Lisa Claire Marguerite Hubert | Board of Directors | 0 companies |